✦ LIBER ✦

CV3 A COST-EFFECTIVENESS ANALYSIS OF CANDESARTAN IN THE TREATMENT OF CHRONIC HEART FAILURE

✍ Scribed by M Lamotte; L Annemans; B Schockaert

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV26 COST-EFFECTIVENESS OF CANDESARTAN

✍ M Voelkl; O Pirk; V Juenger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

CV12 A COST-EFFECTIVENESS ANALYSIS OF AC

✍ H Lilliu; C Le Pen; K Lamiraud; W Wittenberg 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

CV2 THE COST-EFFECTIVENESS OF CANDESARTA

✍ LÅ Levin; E Jørgensen; B Eriksson; K Swedberg; T Paulsson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Cost-Effectiveness Analysis of Ivabradin

✍ Borowiec, L.; Faluta, T.; Filipiak, K.J.; Niewada, M.; Wrona, W. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PP-061 THE COST-EFFECTIVENESS OF BETABLL

✍ Mimoza Lezha; Mirela Miraci; Artan Deliana; Eliverta Zera; Indrit Temali 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 79 KB

PCV21 COST EFFECTIVENESS ANALYSIS OF BIS

✍ E Menditto; S De Portu; S Cammarota; L Scalone; LG Mantovani 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB